age
increas
risk
variou
diseas
main
goal
age
research
find
therapi
attenu
age
allevi
agingrel
diseas
studi
screen
natur
product
librari
geroprotect
compound
use
werner
syndrom
ws
human
mesenchym
stem
cell
hmsc
prematur
age
model
recent
establish
ten
candid
compound
identifi
quercetin
investig
detail
due
lead
effect
mechanist
studi
reveal
quercetin
allevi
senesc
via
enhanc
cell
prolifer
restor
heterochromatin
architectur
ws
hmsc
rnasequenc
analysi
reveal
transcript
common
differ
geroprotect
effect
quercetin
vitamin
c
besid
ws
hmsc
quercetin
also
attenu
cellular
senesc
hutchinsongilford
progeria
syndrom
hgp
physiologicalag
hmsc
taken
togeth
studi
identifi
quercetin
geroprotect
agent
acceler
natur
age
hmsc
provid
potenti
therapeut
intervent
treat
ageassoci
disord
age
associ
progress
function
declin
time
cellular
tissu
organism
level
lead
increas
vulner
diseas
includ
cancer
neurodegen
disord
well
cardiovascular
metabol
diseas
benayoun
et
al
campisi
kudlow
et
al
et
al
possibl
mechan
age
includ
free
radic
telomer
shorten
harley
program
senesc
smith
pereirasmith
genom
instabl
lombard
et
al
loss
heterochromatin
architectur
benayoun
et
al
kubben
et
al
ren
et
al
ren
et
al
villeponteau
zhang
et
al
basi
numer
studi
unravel
possibl
mechan
age
uccelli
et
al
continu
effort
put
identif
mani
novel
target
minim
side
effect
et
al
particular
drug
screen
geroprotect
chemic
attract
curios
excit
imagin
throughout
histori
humankind
progeroid
syndrom
group
rare
genet
disord
character
clinic
featur
prematur
age
werner
syndrom
ws
hutchinsongilford
progeria
syndrom
hgp
two
best
character
type
progeria
ws
known
adult
progeria
mainli
character
prematur
age
patholog
associ
degener
mesoderm
tissu
result
symptom
osteoporosi
atherosclerosi
opresko
et
al
ozgenc
loeb
ws
caus
mutat
wrn
gene
result
loss
wrn
protein
express
wrn
particip
continuum
cellular
process
span
dna
replic
transcript
repair
recombin
well
heterochromatin
mainten
telomer
centromer
region
thu
point
ws
pathogenesi
genom
epigenom
instabl
kudlow
et
al
lebel
li
et
al
wu
et
al
zhang
et
al
wellstudi
progeria
hgp
devast
incur
diseas
averag
age
death
year
hennekam
raoul
kreienkamp
et
al
ullrich
gordon
caus
accumul
progerin
truncat
protein
encod
ggc
ggt
singlebas
mutat
lmna
gene
instead
function
nuclear
lamina
protein
lamin
wildtyp
lmna
gene
hgp
patientderiv
cell
usual
exhibit
nuclear
morpholog
abnorm
alter
signal
pathway
genom
epigenet
instabl
prematur
senesc
burtner
kennedi
kubben
et
al
kudlow
et
al
et
al
liu
et
al
liu
et
al
polosak
et
al
ren
et
al
wu
et
al
yang
et
al
ws
hgp
relev
diseas
model
understand
mechan
age
find
effect
treatment
agingassoci
disord
previous
report
vitamin
c
vc
rejuven
ws
hmsc
induc
global
chang
transcriptom
agingrel
gene
li
et
al
addit
vitamin
report
improv
hgp
cellular
phenotyp
reduc
progerin
product
stabil
key
factor
maintain
genom
integr
kreienkamp
et
al
recent
establish
human
stemcellbas
platform
isogen
ws
hgp
hmsc
ident
genet
background
compar
mechanist
studi
age
well
identif
new
drug
discoveri
strategi
progeria
syndrom
physiolog
age
kubben
et
al
li
et
al
liu
et
al
liu
et
al
wu
et
al
zhang
et
al
studi
screen
natur
product
librari
geroprotect
drug
use
ws
hmsc
identifi
ten
candid
compound
includ
quercetin
mechanist
quercetin
allevi
hmsc
senesc
promot
selfrenew
differenti
abil
well
restor
heterochromatin
architectur
ws
hmsc
rnasequenc
analysi
reveal
quercetin
rejuven
ws
hmsc
via
regul
multipl
cellular
process
relat
cell
cycl
chromosom
condens
antioxid
mechanist
common
vcmediat
geroprotect
effect
ws
hmsc
addit
quercetin
rejuven
hgp
well
physiologicalag
hmsc
taken
togeth
data
indic
quercetin
geroprotect
agent
prematur
physiolog
human
age
recent
establish
platform
werner
syndrom
ws
hutchinsongilford
progeria
syndrom
hgp
hmsc
studi
prematur
physiolog
age
fang
et
al
kubben
et
al
li
et
al
wu
et
al
yang
et
al
zhang
et
al
took
advantag
platform
screen
natur
product
compound
capabl
allevi
prematur
senesc
fig
total
natur
product
tabl
evalu
use
ws
hmsc
shortterm
treatment
compound
seven
day
effect
cell
prolifer
compound
evalu
inner
salt
mt
assay
ten
compound
includ
quercetin
dihydr
refer
quercetin
que
chrysophan
acid
licochalcon
luteolin
formononetin
honokiol
berberin
hcl
kaempferol
bergenin
synephrin
fig
tabl
least
higher
cell
prolif
abil
vehicl
control
dmso
identifi
ten
compound
evalu
longterm
treatment
differ
concentr
day
fig
que
select
due
lead
effect
studi
identifi
optim
concentr
que
ws
hmsc
fig
first
treat
midpassag
passag
ws
hmsc
differ
concentr
que
seven
day
cell
prolif
abil
evalu
mt
c
figur
screen
natur
product
librari
ws
hmsc
schemat
screen
strategi
natur
product
librari
geroprotect
drug
b
result
mt
assay
highlight
ten
candid
compound
n
p
vs
vehicl
c
rel
cell
prolif
abil
upon
treatment
ten
candid
compound
indic
concentr
n
assay
show
benefici
effect
que
concentr
rang
nmoll
fig
furthermor
treat
ws
hmsc
passag
differ
concentr
que
longer
term
day
assess
cellular
prolifer
abil
ws
hmsc
passag
identifi
optim
concentr
que
nmoll
mechanist
studi
fig
quetreat
ws
hmsc
abl
express
hmscspecif
marker
includ
fig
que
allevi
senesc
phenotyp
latepassag
ws
hmsc
evidenc
decreas
senesc
marker
fig
increas
telomer
length
fig
increas
cell
prolif
potenti
stain
fig
decreas
dna
damag
respons
marker
fig
reactiv
oxygen
speci
ro
product
et
al
fig
mrna
level
proinflammatori
cytokin
fig
cell
apoptosi
fig
suppress
quetreat
ws
hmsc
addit
quetreat
ws
hmsc
maintain
abil
differenti
toward
multipl
mesoderm
lineag
enhanc
potenti
toward
osteogenesi
chondrogenesi
fig
furthermor
que
attenu
vivo
decay
ws
hmsc
implant
tibiali
anterior
muscl
nude
mice
fig
enhanc
vasculogen
abil
ws
hmsc
implant
fat
pad
nonobes
diabet
nod
scid
mice
fig
taken
togeth
data
suggest
que
allevi
cellular
senesc
promot
selfrenew
differenti
abil
ws
hmsc
lingl
geng
et
al
werner
syndrom
caus
mutat
wrn
gene
encod
recq
dna
helicas
import
dna
replic
chromatin
mainten
li
et
al
wu
et
al
yu
et
al
zhang
et
al
genom
instabl
heterochromatin
disorgan
manifest
ws
pathogenesi
li
et
al
murfuni
et
al
ren
et
al
ren
et
al
seki
et
al
shamanna
et
al
wu
et
al
zhang
et
al
upon
que
treatment
transcript
pericentromer
repetit
sequenc
includ
satellit
downregul
wherea
nuclear
envelop
protein
lamin
transcript
upregul
fig
likewis
protein
level
heterochromatin
marker
also
increas
fig
lastli
direct
visual
nuclear
structur
transmiss
electron
microscop
tem
reveal
use
load
control
data
shown
mean
sem
n
p
vs
ctrl
p
vs
ctrl
c
quantit
pcr
analysi
telomer
length
vehicleand
quetreat
ws
hmsc
passag
data
shown
mean
sem
n
p
vs
ctrl
immunostain
vehicleand
quetreat
ws
hmsc
passag
scale
bar
data
shown
mean
sem
cell
number
p
vs
ctrl
e
immunostain
vehicleand
quetreat
ws
hmsc
passag
scale
bar
percentag
posit
cell
shown
mean
sem
cell
number
p
vs
ctrl
f
fac
measur
reactiv
oxygen
speci
ro
vehicleand
quetreat
ws
hmsc
passag
au
arbitrari
unit
g
rtqpcr
analysi
mrna
level
vehicleand
quetreat
ws
hmsc
passag
data
shown
mean
sem
n
p
vs
ctrl
h
cell
apoptosi
assay
vehicleand
quetreat
ws
hmsc
passag
quantit
data
right
present
mean
sem
n
p
vs
ctrl
allevi
prematur
age
quercetin
research
articl
heterochromatin
loss
reduc
ws
hmsc
upon
que
treatment
fig
taken
togeth
data
suggest
que
repress
heterochromatin
disorgan
prematur
age
hmsc
uncov
molecular
mechan
que
rejuven
ws
hmsc
perform
genomewid
rna
sequenc
rnaseq
correl
coeffici
replic
vehicl
ctrl
quetreat
ws
hmsc
indic
rnaseq
data
high
reproduc
fig
total
upregul
gene
downregul
gene
obtain
quetreat
ws
hmsc
rel
ctrl
log
fold
chang
adjust
p
valu
padj
fig
tabl
proteinprotein
interact
ppi
network
differenti
express
gene
drawn
base
string
databas
fig
gene
ontolog
go
analysi
reveal
upregul
gene
quetreat
ws
hmsc
enrich
biolog
process
includ
cell
cycl
cell
divis
chromosom
segreg
cell
prolifer
fig
consist
gene
set
enrich
analysi
gsea
data
reveal
quetreat
ws
hmsc
enrich
go
term
includ
cell
cycl
condens
chromosom
well
cellular
respons
oxygen
uv
vitamin
fig
contrari
vehicletr
ws
hmsc
enrich
apoptosi
pathway
fig
antiapoptot
function
que
evidenc
increas
transcript
level
typic
antiapoptot
gene
includ
gene
iap
akt
famili
fig
consist
aforement
result
show
decreas
cell
apoptosi
quetreat
ws
hmsc
investig
whether
que
directli
involv
regul
age
biolog
process
check
transcript
level
age
longevityassoci
gene
annot
human
age
genom
resourc
hagr
databas
gene
express
analysi
show
age
longevityassoci
gene
upregul
p
upon
que
treatment
fig
note
seri
antioxid
gene
includ
gsr
lingl
geng
et
al
upregul
fig
given
gene
respons
gene
test
whether
antioxid
function
que
evalu
express
level
target
gene
result
show
target
gene
upregul
p
upon
que
treatment
fig
increas
express
level
gsr
ws
hmsc
upon
que
treatment
reconfirm
rtqpcr
analysi
fig
taken
togeth
data
suggest
que
rejuven
ws
hmsc
via
regul
multipl
cellular
process
includ
promot
cell
cycl
condens
chromosom
enhanc
antioxid
previous
report
vitamin
c
vc
rejuven
factor
ws
hmsc
alter
express
gene
involv
chromatin
condens
cell
cycl
regul
dna
replic
dna
damag
repair
pathway
li
et
al
perform
conjoint
analysi
rnaseq
data
queand
vctreat
ws
hmsc
compar
contrast
underli
mechan
geroprotect
effect
firstli
upregul
downregul
gene
ws
hmsc
compar
wt
hmsc
revers
either
que
vc
treatment
fig
analyz
upregul
gene
queand
vctreat
ws
hmsc
among
gene
specif
que
treatment
vc
treatment
que
vc
treatment
fig
notabl
commonli
upregul
gene
enrich
biolog
process
go
term
relat
cell
cycl
chromatin
condens
antioxid
wherea
quespecif
upregul
gene
mostli
enrich
respons
stimulu
cell
homeostasi
vcspecif
one
dna
replic
dna
repair
telomer
mainten
fig
thu
data
reveal
major
common
mechan
que
vc
allevi
age
phenotyp
ws
hmsc
besid
ws
hutchinsongilford
progeria
syndrom
hgp
hmsc
anoth
prematur
senesc
stem
cell
model
recent
establish
introduc
heterozyg
quantit
data
right
shown
mean
sem
cell
number
p
vs
ctrl
scale
bar
c
immunoblot
analysi
vehicleand
quetreat
ws
hmsc
passag
use
load
control
quantit
data
shown
mean
sem
n
p
vs
ctrl
p
vs
ctrl
visual
heterochromatin
architectur
vehicleand
quetreat
ws
hmsc
passag
transmiss
electron
microscop
tem
highmagnif
view
heterochromatin
around
nuclear
envelop
shown
right
percentag
cell
spars
heterochromatin
nuclear
peripheri
indic
lower
left
corner
repres
imag
cell
number
scale
bar
allevi
prematur
age
quercetin
research
articl
lmna
mutat
human
embryon
stem
cell
hesc
follow
direct
differenti
hmsc
kubben
et
al
wu
et
al
dna
sequenc
confirm
presenc
heterozyg
mutat
lmna
hgp
hmsc
fig
mrna
level
immunostain
intens
progerin
result
truncat
protein
product
mutat
lmna
decreas
que
vcand
vc
plu
quetreat
hgp
hmsc
fig
allevi
cellular
senesc
que
vc
vc
plu
que
hgp
hmsc
evidenc
decreas
popul
doubl
time
fig
decreas
posit
fig
increas
clonal
expans
prolif
abil
fig
h
addit
percentag
abnorm
nuclei
cellular
hallmark
hgp
decreas
hgp
hmsc
upon
que
treatment
fig
taken
togeth
data
indic
que
attenu
acceler
senesc
hgp
hmsc
examin
geroprotect
effect
que
physiologicalag
pa
wildtyp
hmsc
individu
replicativesenesc
rs
wildtyp
hmsc
differenti
hesc
decreas
popul
doubl
time
posit
reveal
enhanc
selfrenew
suppress
senesc
pa
rs
hmsc
upon
que
treatment
respect
fig
addit
cell
apoptosi
allevi
quetreat
rs
hmsc
fig
result
suggest
besid
progeria
cell
que
also
exert
geroprotect
effect
physiolog
senesc
hmsc
discoveri
compound
attenu
senesc
phenotyp
lead
therapeut
advanc
amelior
agingrel
patholog
chang
et
al
kreienkamp
et
al
li
et
al
employ
platform
prematur
age
werner
syndrom
ws
hmsc
screen
effect
compound
cellular
senesc
phenotyp
identifi
ten
candid
natur
product
includ
quercetin
dihydr
chrysophan
acid
licochalcon
luteolin
formononetin
honokiol
berberin
hcl
kaempferol
bergenin
synephrin
except
que
berberin
hcl
eight
compound
never
implic
prematur
agingrel
studi
thu
greatli
broaden
view
geroprotect
drug
candid
investig
reveal
mechan
top
hit
que
exhibit
benefici
effect
attenu
hmsc
senesc
que
allevi
senesc
promot
stem
cell
selfrenew
restor
heterochromatin
architectur
ws
hmsc
transcriptom
analysi
support
que
improv
healthspan
ws
hmsc
que
vc
exert
geroprotect
effect
overlap
mechan
que
also
allevi
cellular
senesc
phenotyp
hgp
physiologicalag
hmsc
fig
first
time
que
identifi
geroprotect
agent
prematur
physiolog
human
age
support
role
que
novel
therapeut
option
treat
prematur
age
promot
healthi
age
addit
gener
effect
que
verifi
efficaci
ws
hmsc
power
model
geroprotect
drug
screen
que
polyphenol
deriv
plant
c
elegan
que
extend
lifespan
due
antioxid
capac
indirectli
via
activ
homologu
mammalian
foxo
protein
et
al
que
also
report
rejuven
senesc
primari
human
fibroblast
chondrogianni
et
al
prior
studi
effect
que
evalu
progeroid
syndrom
ws
hgp
first
time
uncov
geroprotect
role
que
human
acceler
age
hmsc
quetreat
ws
hmsc
demonstr
improv
differenti
potenti
osteoblast
chondrocyt
enhanc
vivo
vasculogenesi
abil
impli
potenti
therapeut
promis
que
regard
symptom
osteoporosi
atherosclerosi
ws
hgp
patient
particular
observ
que
effect
decreas
progerin
hgp
hmsc
thu
studi
support
que
potenti
therapeut
agent
treat
ws
hgp
clinic
harhouri
et
al
still
vivo
effect
que
rodent
nonhuman
primat
need
investig
effect
highdos
que
previous
evalu
human
cell
mice
combin
dasatinib
highdos
que
mgkg
effect
elimin
senesc
cell
via
induc
apoptosi
thu
allevi
senescencerel
phenotyp
mice
zhu
et
al
allevi
prematur
age
quercetin
research
articl
nonalcohol
fatti
liver
diseas
nafld
mice
combin
dasatinib
que
mgkg
elimin
senesc
cell
reduct
overal
hepat
steatosi
ogrodnik
et
al
senesc
human
preadipocyt
umbil
vein
endotheli
cell
huvec
highdos
que
optim
concentr
respect
induc
apoptot
cell
death
contrast
use
que
nmoll
ws
hgp
physiologicalag
hmsc
effect
allevi
cellular
senesc
without
induc
cell
death
indic
much
safer
therapeut
dose
potenti
applic
stimul
hmsc
activ
determin
molecular
mechan
que
perform
rnaseq
analysi
reveal
upregul
gene
quetreat
ws
hmsc
primarili
lingl
geng
et
al
enrich
cell
cycl
nuclear
divis
chromosom
segreg
pathway
consist
cellular
phenotyp
observ
previou
studi
que
mainli
focus
anticarcinogen
ansgar
darband
saber
et
al
antiinflammatori
griffith
et
al
li
et
al
liu
et
al
salvator
antivir
chiow
et
al
li
et
al
well
antioxid
effect
sohn
et
al
howev
mechan
que
human
stem
cell
age
remain
elucid
first
time
show
que
allevi
hmsc
age
least
partial
via
reduct
ro
restor
heterochromatin
architectur
provid
new
mechan
quemedi
geroprotect
previous
shown
vc
allevi
age
defect
ws
hmsc
decreas
oxid
stress
prevent
telomer
attrit
suppress
excess
secret
inflammatori
factor
well
reorgan
nuclear
lamina
heterochromatin
li
et
al
compar
analysi
rnaseq
data
ws
hmsc
illustr
mechanist
common
differ
geroprotect
effect
que
vc
commonli
upregul
gene
mainli
enrich
gene
term
relat
cell
cycl
chromatin
condens
antioxid
likewis
observ
que
restor
heterochromatin
architectur
decreas
ro
level
ws
hmsc
shown
increas
ro
level
lead
heterochromatin
disorgan
therefor
studi
decreas
ro
level
may
also
contribut
restor
heterochromatin
architectur
addit
recent
demonstr
prematur
age
phenotyp
hgp
hmsc
partial
attribut
repress
antioxid
respons
wherea
reactiv
revers
nuclear
defect
hgp
cell
restor
vivo
viabil
mice
fang
et
al
kubben
et
al
interestingli
que
report
activ
antioxid
pathway
bahar
et
al
dai
et
al
gao
et
al
kim
et
al
consist
rnaseq
analysi
identifi
que
upregul
seri
antioxid
gene
includ
gsr
target
indic
que
may
exert
antioxid
effect
via
activ
furthermor
despit
multipl
mechanist
common
geroprotect
effect
quespecif
upregul
gene
mostli
enrich
respons
stimulu
cell
homeostasi
vcspecif
one
dna
replic
dna
repair
telomer
mainten
rais
possibl
que
vc
combin
might
exhibit
synergist
geroprotect
effect
studi
show
que
vc
exert
cooper
effect
attenu
acceler
senesc
hgp
hmsc
besid
vc
geroprotect
chemic
could
also
strengthen
biolog
activ
que
exampl
resveratrol
que
exhibit
synergist
effect
restor
gene
pathway
glucoselipid
metabol
liver
function
cardiovascular
system
inflammationimmun
mice
fed
highfat
diet
zhou
et
al
move
forward
maxim
geroprotect
effect
que
combin
compon
await
investig
summari
screen
natur
product
librari
ws
hmsc
identifi
que
geroprotect
agent
prematur
physiolog
human
age
detail
mechanist
studi
multilay
evalu
ws
hgp
physiologicalag
hmsc
also
elucid
transcript
common
differ
geroprotect
effect
que
vc
ws
hmsc
addit
given
multidifferenti
potenti
human
pluripot
stem
cell
hpsc
hmsc
platform
ws
hgp
hpsc
hmsc
deriv
provid
power
tool
mechanist
studi
drug
screen
variou
cell
type
cardiovascular
cell
wide
affect
ws
andor
hgp
syndrom
cell
cultur
differenti
wrn
hmsc
lmna
hmsc
obtain
via
direct
differenti
wrn
hesc
lmna
hesc
previous
establish
zhang
et
al
hesc
maintain
mitomycin
cinactiv
mous
embryon
fibroblast
mef
feeder
hesc
cultur
medium
contain
gibco
knockout
serum
replac
gibco
ngml
joint
protein
central
mmoll
nonessenti
amino
acid
neaa
gibco
mmoll
glutamax
gibco
invitrogen
hesc
use
studi
also
cultur
matrigel
bd
bioscienc
mtesr
medium
stemcel
technolog
human
msc
cultur
hmsc
cultur
medium
contain
glutamax
gibco
fetal
bovin
serum
fb
gemcel
lot
b
figur
que
allevi
senesc
hgp
hmsc
synergist
effect
vc
confirm
heterozyg
mutat
lmna
dna
sequenc
b
rtqpcr
analysi
progerin
mrna
express
vehicl
que
vcand
vc
plu
quetreat
hgp
hmsc
passag
data
shown
mean
sem
n
p
vs
ctrl
p
vs
ctrl
c
immunostain
progerin
vehicl
que
vcand
vc
plu
quetreat
hgp
hmsc
passag
scale
bar
mean
fluoresc
intens
right
shown
mean
sem
cell
number
p
vs
ctrl
accumul
growth
curv
show
popul
doubl
hgp
hmsc
upon
treatment
vehicl
que
vc
vc
plu
que
n
e
analysi
activ
vehicl
que
vcand
vc
plu
quetreat
hgp
hmsc
left
repres
imag
stain
passag
right
frequenc
cell
data
shown
mean
sem
n
p
vs
ctrl
p
vs
ctrl
scale
bar
f
clonal
expans
abil
vehicl
que
vcand
vc
plu
quetreat
hgp
hmsc
passag
stain
crystal
violet
quantit
data
shown
mean
sem
n
p
vs
ctrl
p
vs
ctrl
scale
bar
g
immunostain
vehicleand
quetreat
hgp
hmsc
passag
scale
bar
cell
shown
mean
sem
cell
number
p
vs
ctrl
h
quantit
pcr
analysi
telomer
length
vehicleand
quetreat
hgp
hmsc
passag
data
shown
mean
sem
n
p
vs
ctrl
immunostain
lamin
ac
vehicleand
quetreat
hgp
hmsc
passag
quantif
abnorm
nuclei
hgp
hmsc
right
shown
mean
sem
n
p
vs
ctrl
scale
bar
allevi
prematur
age
quercetin
research
articl
ngml
joint
protein
central
penicillin
streptomycin
gibco
differenti
hesc
mesenchym
stem
cell
msc
perform
describ
previous
duan
et
al
fu
et
al
wang
et
al
wang
et
al
zhang
et
al
briefli
embryoid
bodi
cultur
matrigelco
plate
hmsc
differenti
medium
glutamax
gibco
fb
gemcel
lot
ngml
joint
protein
central
ngml
stemimmun
llc
penicillinstreptomycin
gibco
day
confluent
msclike
cell
passag
gelatinco
plate
cultur
hmsc
cultur
medium
contain
glutamax
gibco
fetal
bovin
serum
fb
gemcel
lot
ngml
joint
protein
central
penicillinstreptomycin
gibco
e
cell
apoptosi
assay
vehicleand
quetreat
rs
hmsc
passag
quantit
data
right
shown
mean
sem
n
p
vs
ctrl
lingl
geng
et
al
vitro
differenti
potenti
ws
hmsc
osteoblast
chondrocyt
adipocyt
pan
et
al
wu
et
al
zhang
et
al
evalu
von
kossa
abcam
toluidin
blue
sigma
oil
red
sigma
stain
respect
physiologicalag
pa
hmsc
isol
gingiva
male
individu
year
old
detail
piec
tissu
size
approxim
mm
mm
mm
obtain
gingiv
lamina
propria
free
gingiva
remov
gingiv
epithelium
tissu
wash
pb
minc
small
piec
follow
digest
collagenas
min
hmsc
collect
upon
centrifug
rpm
min
cultur
hmsc
cultur
medium
human
msc
purifi
sort
tripl
posit
cell
use
fac
detail
hmsc
digest
use
trypl
express
gibco
wash
twice
pb
cell
incub
primari
antibodi
dilut
fb
pb
min
room
temperatur
sort
use
flow
cytomet
bd
facsaria
iiiu
total
compound
natur
product
librari
selleck
purchas
screen
ws
hmsc
initi
ws
hmsc
passag
seed
drugstamp
plate
densiti
cell
per
well
cultur
medium
differ
kind
compound
chang
everi
day
seven
day
drug
treatment
cell
prolifer
measur
mt
assay
promega
valu
quintic
treatment
well
averag
normal
quintic
control
well
top
candid
compound
screen
treatment
four
differ
concentr
nmoll
ws
hmsc
passag
seed
plate
densiti
cell
per
well
cultur
medium
differ
kind
candid
compound
chang
everi
day
rel
cell
prolif
abil
ws
hmsc
passag
treat
compound
differ
concentr
analyz
day
determin
optim
que
concentr
ws
hmsc
passag
seed
plate
densiti
cell
per
well
treat
differ
concentr
quercetin
hydrat
que
tci
cultur
medium
que
chang
everi
day
seven
day
drug
treatment
cell
prolifer
measur
mt
assay
promega
valu
quintic
treatment
well
averag
normal
quintic
control
well
process
calcul
log
quevehicl
control
senescenceassoci
stain
perform
describ
previous
debacqchainiaux
et
al
briefli
hmsc
wash
pb
fix
room
temperatur
min
formaldehyd
glutaraldehyd
fix
cell
stain
freshli
prepar
stain
solut
activ
overnight
imag
taken
percentag
posit
cell
calcul
singlecel
clonal
expans
assay
carri
describ
duan
et
al
wu
et
al
briefli
ws
hmsc
plate
densiti
cell
per
well
gelatin
coat
plate
treat
vehicl
que
cell
densiti
calcul
crystal
violet
stain
allevi
prematur
age
quercetin
western
blot
cell
collect
lyse
ripa
buffer
sd
mmoll
trishcl
ph
sodium
deoxychol
mmoll
nacl
supplement
navo
naf
proteaseinhibitor
mixtur
roch
bca
kit
thermo
fisher
scientif
use
measur
protein
concentr
protein
sampl
separ
sdspage
transfer
onto
pvdf
membran
millipor
membran
incub
primari
antibodi
hrpconjug
secondari
antibodi
quantif
perform
imag
lab
softwar
chemidoc
xr
system
biorad
total
rna
extract
use
trizol
reagent
invitrogen
total
rna
convert
cdna
use
goscript
revers
transcript
system
promega
quantit
realtim
pcr
perform
itaq
univers
sybr
green
super
mix
biorad
realtim
pcr
system
biorad
data
normal
rrna
transcript
calcul
use
method
quantit
rtpcr
primer
use
list
tabl
cell
prepar
previous
report
briefli
hmsc
seed
microscop
coverslip
fix
formaldehyd
pb
min
permeabil
triton
pb
min
block
donkey
serum
pb
h
hmsc
coverslip
incub
primari
antibodi
dilut
donkey
serum
pb
overnight
incub
fluorescencelabel
secondari
antibodi
dilut
donkey
serum
pb
room
temperatur
h
hoechst
invitrogen
use
stain
nuclear
dna
vivo
stem
cell
retent
analysi
ws
hmsc
implant
perform
previous
describ
brief
luciferaseexpress
ws
hmsc
pretreat
vehicl
nmoll
que
day
implant
middl
tibiali
anterior
muscl
immunodefici
mice
five
day
implant
mice
anaesthet
inject
dluciferin
solut
goldbio
min
vivo
luciferas
activ
mous
determin
ivi
lumina
system
perkinelm
luminesc
intens
normal
luciferas
intens
hmsc
right
implant
anim
experi
perform
studi
approv
institut
biophys
chines
academi
scienc
fat
pad
transplant
perform
previous
describ
yu
et
al
freshli
collect
vehicleor
quetreat
ws
hmsc
passag
resuspend
matrigel
mixtur
consist
matrigel
fb
pb
trypan
blue
sigma
cell
volum
inject
fat
pad
femal
nonobes
diabet
nod
scid
mice
fat
pad
harvest
week
posttransplant
measur
donorderiv
vessel
regener
immunofluoresc
stain
ws
hmsc
treat
vehicl
que
passag
collect
passag
rnaseq
analysi
use
illumina
sequenc
platform
rna
sequenc
librari
prepar
previous
report
li
et
al
zhang
et
al
briefli
rna
integr
examin
bioanalyz
system
agil
technolog
sequenc
librari
construct
use
nebnext
ultratm
rna
librari
prep
kit
illumina
neb
sequenc
illumina
hiseq
x
ten
platform
pipelin
rnaseq
data
process
describ
previous
brief
sequenc
read
trim
map
human
genom
use
softwar
kim
et
al
transcript
express
level
gene
count
htseq
ander
et
al
differenti
express
gene
deg
comput
use
cutoff
adjust
p
valu
benjaminihochberg
less
log
fold
chang
love
et
al
correl
replic
sampl
evalu
pearson
correl
coeffici
r
base
regularizedlogarithm
rlog
normal
read
count
gene
ontolog
go
pathway
enrich
analysi
conduct
toppgen
chen
et
al
proteinprotein
interact
network
differenti
express
gene
drawn
base
string
databas
szklarczyk
et
al
transcript
level
agingand
longevityassoci
gene
well
target
gene
analyz
agingand
longevityassoci
gene
identifi
accord
human
age
genom
resourc
hagr
databas
target
gene
transcript
factor
target
molecular
signatur
databas
msigdb
gsea
addit
gene
previous
report
kubben
et
al
reszka
et
al
tacutu
et
al
gene
adjust
p
valu
benjaminihochberg
less
analyz
p
valu
calcul
twosampl
kolmogorovsmirnov
test
rnaseq
data
deposit
ncbi
gene
express
omnibu
geo
databas
access
number
primari
antibodi
fac
bioscienc
ebiosci
primari
antibodi
western
blot
antiwrn
santa
cruz
biotechnolog
cell
signal
technolog
bd
bioscienc
antibodi
immunofluoresc
stain
antihsma
zsgbbio
antiprogerin
antilamin
ac
santa
cruz
biotechnolog
cell
signal
technolog
bethyl
laboratori
millipor
anti
lingl
geng
et
al
